Abstract:As one of the serious complications in patients with lung cancer, brain metastasis (BM) have been demonstrated more common when patients were diagnosing with small-cell-lung cancer (SCLC). After developing a BM, patients' median overall survival will be obviously shorten. Prophylactic Cranial Irradiation (PCI) used to be an optimal therapy to prevent the occurrence of BM in SCLC patients, while recently its status was shaken. This retrospective study aimed to find out the potential risk factor relative to the incidence of BM and construct a predictive mode for SCLC, also to see the efficiency of PCI on SCLC patients' ICPFS. Patients pathologically diagnosed with SCLC were consecutively enrolled from May 1st 2006 to February 15th 2019 and reviewed. The intracranial progression-free survival (ICPFS) were calculated by a Kaplan-Meier approach. And the candidate prognosticators of the ICPFS were checked by COX regression analysis. Using these risk factor and its coefficient obtained in the multivariate analysis, a model were constructed to anticipate the incidence of BM. And the receiver-operating characteristic (ROC) curve was constructed to access the prediction ability. Totally 261 SCLC patients were eligible for analysis, including 78 cases had developed a BM (29.9%) after the first diagnosis. We used Cox proportional hazards to analyze and adjust the confounding factor to the incidence of BM, and got the result, that there were five factors showed the significance both in Uni-(P<0.15) and multivariate(P<0.05) analysis, including smoking index <400(P=0.017); vascular invasion (P=0.012); number of primary lesion (P=0.042); staging (P=0.018); and hyponatremia (P=0.05). And a predicative model was constructed by using these factors (except the hyponatremia), with an AUC value of 0.743. And we used this model to distinguish low and high risk group. Two groups' ICPFS showed a remarkable significance (P<0.001). We also simplified it to make it more convenient in clinical work, which also showed an outstanding significance (P<0.001). However, the PCI in our study was not reach the significance, even though it prolonged the ICPFS (P=0.211). Factors included smoking index >=400, vascular invasion, number of primary lesion, staging, and hyponatremia, increasing the risk of BM occurrence. In the era of individualized treatment, a predictive model based on smoking status and image science can give some suggestions for clinical work by anticipating the highly risky incidence of brain metastasis on SCLC patients.

Clinical features and biological markers of lung cancer-associated stroke.

Clinical Characteristics and Risk Factors of Lung Cancer-Associated Acute Ischemic Stroke

Clinical features and prognostic factors of patients with cancer-associated stroke

Diagnosing cancer-associated ischemic stroke: A systematic review of hematological biomarkers

D-dimer and diffusion-weighted imaging pattern as two diagnostic indicators for cancer-related stroke: A case-control study based on the STROBE guidelines.

The biomarkers and potential pathogenesis of lung cancer related cerebral hemorrhage

Clinical Features Of Systemic Cancer Patients With Acute Cerebral Infarction And Its Underlying Pathogenesis

Biomarkers of gastric cancer-related ischemic stroke and its underlying pathogenesis.

Short-term outcomes in patients with lung cancer-associated acute ischemic stroke

P2.12-22 Risk Factors for BM Incidence in SCLC: A Predictive Model for SCLC Patients on Brain Metastasis

Biomarker and genomic analyses reveal molecular signatures of non-cardioembolic ischemic stroke

Stroke Prognosis: the Impact of Combined Thrombotic, Lipid, and Inflammatory Markers

Stroke Exacerbates Cancer Progression by Upregulating LCN2 in PMN-MDSC

Recurrent Stroke in a Patient of Lung Cancer Without Pulmonary Mass

Clinical characteristics of breast cancer complicated by cerebral infarction

Development of an algorithm for identifying paraneoplastic ischemic stroke in association with lung, pancreatic, and colorectal cancer

Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach

Risk Factors and Biomarkers of Ischemic Stroke in Cancer Patients

A clinical research on the potential pathogenesis of somatic cancer related cerebral venous sinus thrombosis.

Differences of Circulating Inflammatory Markers Between Large- and Small Vessel Disease in Patients with Acute Ischemic Stroke

Post-Stroke Cognitive Impairment: A Review Focusing on Molecular Biomarkers